Top

Published in:

01-08-2023 | Myocarditis | Clinical study

Pfizer-BioNTech COVID-19 vaccine increases risk of myocarditis/pericarditis

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Vaccination with the Pfizer-BioNTech COVID-19 vaccine [BNT162b2] increases the risk of myocarditis and pericarditis, according to findings of a New Zealand study published in Drug Safety . …

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand Drug Safety : 9 Aug 2023. Available from: URL: https://doi.org/10.1007/s40264-023-01332-1

Title: Pfizer-BioNTech COVID-19 vaccine increases risk of myocarditis/pericarditis
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Myocarditis
COVID-19 Vaccination
Vasculitis
Vasculitis
Erythema Exsudativum Multiforme
Erythema Exsudativum Multiforme
Thrombosis
Vaccination
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45136-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pfizer-BioNTech COVID-19 vaccine increases risk of myocarditis/pericarditis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Carbamazepine/clobazam/valproate

Apixaban

Rituximab

Metformin

Evolocumab

Arsenic-trioxide/tretinoin